论文部分内容阅读
目前科学家对研制一种抗血吸虫病或抗血吸虫属的有效疫苗愈来愈充满信心。最近的研究是在英国贝克纳姆地方的肯特Wellcome实验室和美国华盛顿大学进行的。 1983年在研究血吸虫疫苗方面迈出了关键性的一步,剑桥大学病理系Anthony Bntterworth领导的研究小组发现有些人对血吸虫病具有自然免疫力。一些来自流行血吸虫病的肯尼亚地区的儿童在感染血吸虫毛蚴和成虫后,约30％的儿童经药物治疗杀死虫体后未再复发。
At present, scientists are increasingly confident of developing an effective anti-schistosomiasis or anti-schistosoma vaccine. Recent research is conducted at Kent Wellcome Laboratories in Barkham, UK, and at Washington University in the United States. A crucial step toward schistosomiasis vaccine research was taken in 1983, when a team led by Anthony Bntterworth, a pathologist at the University of Cambridge, found that some people are naturally immune to schistosomiasis. Some children from the endemic schistosomiasis population in Kenya experience infection with schistosome miracles and adults, and about 30% of children relapse after drug treatment kill the worms.